| 1 |
Qureshi AI, Mendelow AD, Hanley DF. Intracerebral haemorrhage [J]. Lancet, 2009, 373(9675): 1632-1644.
|
| 2 |
van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis [J]. Lancet Neurol, 2010, 9(2): 167-176.
|
| 3 |
Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review [J]. Lancet Neurol, 2009, 8(4): 355-369.
|
| 4 |
Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage [J]. Neurology, 2006, 66(8): 1175-1181.
|
| 5 |
Fujii Y, Takeuchi S, Sasaki O, et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage [J]. Stroke, 1998, 29(6): 1160-1166.
|
| 6 |
Kazui S, Naritomi H, Yamamoto H, et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course [J]. Stroke, 1996, 27(10): 1783-1787.
|
| 7 |
Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage [J]. Stroke, 1997, 28(1): 1-5.
|
| 8 |
Leira R, Davalos A, Silva Y, et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors [J]. Neurology, 2004, 63(3): 461-467.
|
| 9 |
Delcourt C, Huang Y, Arima H, et al. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study [J]. Neurology, 2012, 79(4): 314-319.
|
| 10 |
Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage [J]. Cerebrovasc Dis, 2013, 35(3): 195-201.
|
| 11 |
Dowlatshahi D, Demchuk AM, Flaherty ML, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes [J]. Neurology, 2011, 76(14): 1238-1244.
|
| 12 |
Brouwers HB, Falcone GJ, Mcnamara KA, et al. CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage [J]. Neurocrit Care, 2012, 17(3): 421-428.
|
| 13 |
Fisher CM. Pathological observations in hypertensive cerebral hemorrhage [J]. J Neuropathol Exp Neurol, 1971, 30(3): 536-550.
|
| 14 |
Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage [J]. J Neurosurg, 1994, 80(1): 51-57.
|
| 15 |
Delgado AJ, Yoo AJ, Stone MJ, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score [J]. Stroke, 2009, 40(9): 2994-3000.
|
| 16 |
Ederies A, Demchuk A, Chia T, et al. Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients [J]. Stroke, 2009, 40(5): 1672-1676.
|
| 17 |
Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis [J]. Stroke, 2007, 38(3): 1072-1075.
|
| 18 |
陈国芳, 秦晓凌, 平蕾, 等. 原发性脑出血早期血肿增大的临床分析 [J]. 中华神经科杂志, 2009, 42(7): 484-485.
|
| 19 |
Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage [J]. Neurology, 2005, 65(7): 1000-1004.
|
| 20 |
Cucchiara B, Messe S, Sansing L, et al. Hematoma growth in oral anticoagulant related intracerebral hemorrhage [J]. Stroke, 2008, 39(11): 2993-2996.
|
| 21 |
Maruishi M, Shima T, Okada Y, et al. Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma [J]. Neurol Med Chir (Tokyo), 2001, 41(6): 300-304, 304-305.
|
| 22 |
Wada R, Aviv RI, Fox AJ, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage [J]. Stroke, 2007, 38(4): 1257-1262.
|
| 23 |
Li Q, Liu Q J, Yang WS, et al. Island Sign: An Imaging Predictor for Early Hematoma Expansion and Poor Outcome in Patients With Intracerebral Hemorrhage [J]. Stroke, 2017, 48(11): 3019-3025.
|
| 24 |
Li Q, Zhang G, Huang YJ, et al. Blend Sign on Computed Tomography: Novel and Reliable Predictor for Early Hematoma Growth in Patients With Intracerebral Hemorrhage [J]. Stroke, 2015, 46(8): 2119-2123.
|
| 25 |
Li Q, Zhang G, Xiong X, et al. Black Hole Sign: Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage [J]. Stroke, 2016, 47(7): 1777-1781.
|
| 26 |
Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage [J]. Neurology, 2007, 68(12): 889-894.
|
| 27 |
Li N, Wang Y, Wang W, et al. Contrast extravasation on computed tomography angiography predicts clinical outcome in primary intracerebral hemorrhage: a prospective study of 139 cases [J]. Stroke, 2011, 42(12): 3441-3446.
|
| 28 |
Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study [J]. Lancet Neurol, 2012, 11(4): 307-314.
|
| 29 |
Barras CD, Tress BM, Christensen S, et al. Density and shape as CT predictors of intracerebral hemorrhage growth [J]. Stroke, 2009, 40(4): 1325-1331.
|
| 30 |
Barras CD, Tress BM, Christensen S, et al. Quantitative CT densitometry for predicting intracerebral hemorrhage growth [J]. AJNR Am J Neuroradiol, 2013, 34(6): 1139-1144.
|
| 31 |
Boulouis G, Morotti A, Brouwers HB, et al. Association Between Hypodensities Detected by Computed Tomography and Hematoma Expansion in Patients With Intracerebral Hemorrhage [J]. JAMA Neurol, 2016, 73(8): 961-968.
|
| 32 |
陆菁菁, 季楠, 赵元立, 等. 进展型脑出血的影像学和临床预测 [J]. 中华医学杂志, 2007, 87(7): 438-441.
|
| 33 |
Ng D, Churilov L, Mitchell P, et al. The CT Swirl Sign Is Associated with Hematoma Expansion in Intracerebral Hemorrhage [J]. AJNR Am J Neuroradiol, 2018, 39(2): 232-237.
|
| 34 |
李卓星, 褚晓凡, 窦汝香, 等. 不规则血肿形态的量化评价 [J]. 中华神经科杂志, 2008, 41(5): 335-338.
|
| 35 |
Yogendrakumar V, Demchuk AM, Aviv RI, et al. Location of intracerebral haemorrhage predicts haematoma expansion [J]. Eur Stroke J, 2017, 2(3): 257-263.
|
| 36 |
Lee SM, Park HS, Choi JH, et al. Location and characteristics of warfarin associated intracranial hemorrhage [J]. J Cerebrovasc Endovasc Neurosurg, 2014, 16(3): 184-192.
|
| 37 |
Brouwers HB, Biffi A, Ayres AM, et al. Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage [J]. Stroke, 2012, 43(6): 1490-1495.
|
| 38 |
Roh D, Sun CH, Murthy S, et al. Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage [J]. Neurocrit Care, 2019, 31(1): 40-45.
|
| 39 |
Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage [J]. N Engl J Med, 2005, 352(8): 777-785.
|
| 40 |
Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [J]. N Engl J Med, 2008, 358(20): 2127-2137.
|
| 41 |
Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor Ⅶ? [J]. Stroke, 2009, 40(3): 833-840.
|
| 42 |
Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial [J]. Lancet Neurol, 2008, 7(5): 391-399.
|
| 43 |
Anderson CS, Huang Y, Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT) [J]. Stroke, 2010, 41(2): 307-312.
|
| 44 |
Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage [J]. N Engl J Med, 2013, 368(25): 2355-2365.
|
| 45 |
Qureshi AI, Palesch YY, Martin R, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study [J]. Arch Neurol, 2010, 67(5): 570-576.
|
| 46 |
Arima H, Anderson CS, Wang JG, et al. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage [J]. Hypertension, 2010, 56(5): 852-858.
|
| 47 |
Qureshi AI, Palesch YY, Barsan WG, et al. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage [J]. N Engl J Med, 2016, 375(11): 1033-1043.
|
| 48 |
Huang LQ, Zhu GF, Deng YY, et al. Hypertonic saline alleviates cerebral edema by inhibiting microglia-derived TNF-α and IL-1β-induced Na-K-Cl Cotransporter up-regulation [J]. J Neuroinflammation, 2014, 11: 102.
|
| 49 |
Hauer EM, Stark D, Staykov D, et al. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease [J]. Crit Care Med, 2011, 39(7): 1766-1772.
|
| 50 |
Wagner I, Hauer EM, Staykov D, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution [J]. Stroke, 2011, 42(6):1540-1545.
|
| 51 |
Schreibman DL, Hong CM, Keledjian K, et al. Mannitol and Hypertonic Saline Reduce Swelling and Modulate Inflammatory Markers in a Rat Model of Intracerebral Hemorrhage [J]. Neurocrit Care, 2018, 29(2): 253-263.
|
| 52 |
Qureshi AI, Suri MF, Ringer AJ, et al. Regional intraparenchymal pressure differences in experimental intracerebral hemorrhage: effect of hypertonic saline [J]. Crit Care Med, 2002, 30(2): 435-441.
|
| 53 |
Koenig MA, Bryan M, JL3rd Lewin, et al. Reversal of transtentorial herniation with hypertonic saline [J]. Neurology, 2008, 70(13): 1023-1029.
|
| 54 |
Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline [J]. Neurosurgery, 1999, 44(5): 1055-1064.
|
| 55 |
Harutjunyan L, Holz C, Rieger A, et al. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients-a randomized clinical trial [ISRCTN62699180] [J]. Crit Care, 2005, 9(5): R530-R540.
|
| 56 |
Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials [J]. Crit Care Med, 2011, 39(3): 554-559.
|